Meta Analysis for Interleukin-6 (IL6)

Meta Calculation for Within-subject

ID Meta Analysis Type Median Lower CI Upper CI
1516 Within-subject 43.6 37.1 51.6

References used in meta calculation

Meta Calculation for Within-subject

ID Meta Analysis Type Median Lower CI Upper CI
1508 Within-subject 31.9 21.5 51.6

References used in meta calculation

Reference
Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013, Cytokine, 64, 660–665 , Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays

Originally from this reference: Cytokine, Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013


id: 0538
Reference
Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013, Cytokine, 64, 660–665 , Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays

Originally from this reference: Cytokine, Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013


id: 0538
Reference
Picotte M, Campbell CG, Thorland WG, 2009, Cytokine, 47, 162–165 , Day-to-day variation in plasma interleukin-6 concentrations in older adults

Originally from this reference: Cytokine, Picotte M, Campbell CG, Thorland WG, 2009


id: 0540
Reference
Cava F, Gonza ́lez C, Pascual MJ, Navajo JA, Gonza ́lez-Buitrago JM, 2000, CYTOKINE, 12(9), 1423–1425 , Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals

Originally from this reference: CYTOKINE, Cava F, Gonza ́lez C, Pascual MJ, Navajo JA, Gonza ́lez-Buitrago JM, 2000


id: 0539
Reference
Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW, 2019, BMC Immunol, 20(33), , Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests

Originally from this reference: BMC Immunol, Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW, 2019


id: 0488

Meta Calculation for Within-subject

ID Meta Analysis Type Median Lower CI Upper CI
1510 Within-subject 31.9 21.5 51.6

References used in meta calculation

Meta Calculation for Between-subject

ID Meta Analysis Type Median Lower CI Upper CI
1517 Between-subject 72.5 41.7 185.9

References used in meta calculation

Meta Calculation for Between-subject

ID Meta Analysis Type Median Lower CI Upper CI
1511 Between-subject 39.2 26.4 185.9

References used in meta calculation

Meta Calculation for Between-subject

ID Meta Analysis Type Median Lower CI Upper CI
1509 Between-subject 39.2 26.4 185.9

References used in meta calculation

Reference
Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013, Cytokine, 64, 660–665 , Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays

Originally from this reference: Cytokine, Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013


id: 0538
Reference
Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013, Cytokine, 64, 660–665 , Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays

Originally from this reference: Cytokine, Todd J, Simpson P, Estis J, Torres V, Wub A HB, 2013


id: 0538
Reference
Picotte M, Campbell CG, Thorland WG, 2009, Cytokine, 47, 162–165 , Day-to-day variation in plasma interleukin-6 concentrations in older adults

Originally from this reference: Cytokine, Picotte M, Campbell CG, Thorland WG, 2009


id: 0540
Reference
Cava F, Gonza ́lez C, Pascual MJ, Navajo JA, Gonza ́lez-Buitrago JM, 2000, CYTOKINE, 12(9), 1423–1425 , Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals

Originally from this reference: CYTOKINE, Cava F, Gonza ́lez C, Pascual MJ, Navajo JA, Gonza ́lez-Buitrago JM, 2000


id: 0539
Reference
Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW, 2019, BMC Immunol, 20(33), , Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests

Originally from this reference: BMC Immunol, Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW, 2019


id: 0488